FDA Approves Teva’s Generic of Mylan’s EpiPen

The EpiPen — which injects a dose of epinephrine to someone in a life-threatening allergy attack — has a competitor. Drug giant Mylan has held the purse strings to the drug for years, and raised the prices for it to astronomical levels to the point that, besides breaking the pocketbooks of those need the pens, overcharged the U.S. government so much that the company had to pay back $465 million to the feds. Ironically, Mylan created its own generic competition, but Thursday the U.S....

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports